Cervical Papanicolaou smear abnormalities in Inner City Bronx adolescents: Prevalence, progression, and immune modifiers

Cancer

Volumn 87, Issue 4, 1999, Pages 184-189

  Edelman, Morris ^a   Fox, Amy S ^a   Alderman, Elizabeth M ^a   Neal, Wendy ^a   Shapiro, Alan ^a   Silver, Ellen J ^a   Spigland, Ilya ^a   Suhrland, Mark ^a,b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

Adolescent; Cervical intraepithelial neoplasia; Cytology; Immune deficiency; Papanicoloau smear

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOMODULATION; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PRIORITY JOURNAL; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY;

EID: 0033603778     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0142(19990825)87:4<184::aid-cncr4>3.0.co;2-%23     Document Type: Article

References (43)

1. Cannistra SA, Niloff JM. Cancer of the uterine cervix. N Engl J Med 1996;334:1030-8.
2. Crowther ME. Is the nature of cervical carcinoma changing in young women? Obstet Gynecol Surv 1994;50:71-82.
3. Schiffman MH, Brinton LA. The epidemiology of cervical carcinogenesis. Cancer 1995;76:1890-1901.
4. Koss LG. The Papanicolaou test for cervical cancer detection: a triumph and a tragedy. JAMA 1989;261:737-43.
5. Fisher M, Rosenfeld WD, Burk RD. Cervicovaginal human papillomavirus infection in suburban adolescents and young adults. J Pediatr 1991;119:821-5.
6. Stone KM, Zaidi A, Rosero-Bixby L, Oberle MW, Reynolds G, Larsen S, et al. Sexual behavior, sexually transmitted disease and the risk of cervical cancer. Epidemiology 1995;6:409-14.
7. Center for Disease Control. Premarital sexual experience among adolescent women, United States, 1970-1988. MMWR CDC Surveill Summ 1991;39:929-32.
8. Roye C. Abnormal cervical cytology in adolescents: a literature review. J Adolesc Health 1992;13:643-50.
9. Kurman RJ, Solomon D. The Bethesda system for reporting cervical/vaginal cytologic diagnoses. Springer-Verlag, 1994.
10. Hein K, Schreiber K, Cohen M, Koss L. Cervical cytology: the need for routine screening in the sexually active adolescent. J Pediatr 1977;91:123-6.
11. Rosenthal D, Strumwasser J, Wiesmeier E, Forsythe A. Changing patterns of cervical disease in a student population. College Health 1982;30:257-9.
12. Sadeghi S, Hsieh E, Gunn S. Prevalence of cervical intraepithelial neoplasia in sexually active teenagers and young adults. Am J Obstet Gynecol 1984;148:726-9.
13. Mcquiston C. The relationship of risk factors for cervical cancer and HPV in college women. Nurse Pract 1989;14:18-26.
14. Mangan SA, Legano LA, Rosen CM, McHugh MT, Fierman AH, Dreyer BP, et al. Increased prevalence of abnormal Papanicolaou smears in urban adolescents. Arch Pediatr Adolesc Med 1997;151:481-4.
15. Hassan E, Relikas C, Matalliotakis I, Kalogeraki A, Koffa M, Delides G, et al. Cervical cytology in adolescents. Clin Exp Adolesc Gynecol 1997;24:28-30.
16. Learmonth GM, Duncan CM, Beck JD. The changing incidence of cervical intraepithelial neoplasia. S Afr Med J 1990; 77:637-9.
17. Jones DED, Russo J, Dombroski RA, Lentz SS. Cervical intraepithelial neoplasia in adolescents. J Adolesc Health 1984; 5:243-7.
18. Economos K, Perz-Veridiano N, Mann M, Delke I, Tancer ML. Abnormal cervical cytology in adolescents: a 15-year experience. J Reprod Med 1994;39:973-6.
19. Hillard PJA, Biro FM, Wildey LS, et al. Cervical dysplasia and human papillomavirus: evaluation in an adolescent dysplasia clinic. Adolesc Pediatr Gynecol 1989;2:32-6.
20. Hillard PJA. Adolescent Pap smears screening: yes or no. In: Opinions in pediatric and adolescent gynecology. Brown RT, editor. J Pediatr Adolesc Gynecol 1996;9:93-7.
21. Rader AE, Lazebnick R, Arora CD, Franklin J, Abdul-Karim FW. Atypical squamous cells of undetermined significance in the pediatric population: implications for management and comparison with the adult population. Acta Cytol 1997; 41:1073-8.
22. Williams ML, Rimm DL, Pedigo MA, Frable WJ. Atypical squamous cells of undetermined significance: correlative histologic and follow-up studies from an academic medical center. Diagn Cytol 1997;16: 1-7.
23. Yang M, Zacheriah S. ASCUS on cervical cytological smears: clinical significance. J Reprod Med 1997;42:329-31.
24. Renshaw AA, Lee KR, Granter SR. Use of statistical analysis of cytologic interpretation to determine the causes of interobserver disagreement and in quality improvement. Cancer 1997;81:212-9.
25. Moscicki AB, Palefsky J, Gonzales J, Schoolnik GK. Human papillomavirus infection in sexually active adolescent females: prevalence and risk factors. Pediatr Res 1990;28:507-13.
26. Crum CP, McLachlin CM. Cervical intraepithelial neoplasia. J Cell Biochem 1995; 23(Suppl):71-9.
27. Mayeaux EJ, Harper MB, Abreo, Pope JB, Phillips GS. A comparison of the reliability of repeat cervical smears and colposcopy in patients with abnormal cytology. J Fam Practice 1995;40:57-62.
28. Parham GP, Shaver M, Brown P, Zumwalt T, Salem F, Savage EW. Significance of a first time atypical Papanicoloau smear in a young, high risk African American and Latino-American population. J Natl Med Assoc 1994;86:273-7.
29. van Oortmassen GJ, Habbema JDF. Epidemiological evidence for age dependent regression of pre-invasive cervical cancer. Br J Cancer 1991;64:559-65.
30. Bos AB, van Ballegegooijen, van Oortmassen GJ, van Marie ME, Habbema JD, Lynge E. Non-progression of cervical intraepithelial neoplasia estimated from population screening data. Br J Cancer 1997;75:124-30.
31. Koss LG. Epidermoid carcinoma of the uterine cervix and related precursor lesions. In: Diagnostic cytology and its histopathologic bases. 4th edition. Philadelphia: J. B. Lippincott.
32. Baccalon M, Tirelli U, Sopracordevole F, Vaccher E. Intraepithelial and invasive cervical neoplasia during HIV infection. Eur J Cancer 1996;32A:2212-7.
33. Petry KU, Scheffel D, Bode U, Gabrysiak T, Kochel H, Kupsch E, et al. Cellular immunodeficiency enhances the progression of human papillomavirus-associated cervical lesions. Int J Cancer 1994;57:836-40.
34. Maiman M, Fruchter RG, Serur E, Levine PA, Arrastia CD, Sedlis A. Recurrent cervical intraepithelial neoplasia in human immunodeficiency virus-seropositive woman. Obstet Gynecol 1993;82:170-4.
35. Wright TC, Ellerbrock TV, Chiasson MA, van Devanter N, Sun XW. Cervical intraepithelial neoplasia in woman infected with human immunodeficiency virus: prevalence, risk factors and the validity of Papanicolaou smears. Obstet Gynecol 1994;84:591-7.
36. Murphy M, Pomeroy L, Tynan M, Murphy JF, Mulcahy FM. Cervical cytological screening in HIV-infected woman in Dublin: a six-year review. Int J STD AIDS 1995;6:262-6.
37. Balachandran I, Galagan KS. Cervical carcinoma in situ associated with azathioprine therapy: a case report and literature review. Acta Cytol 1984;28:699-702.
38. Scheider V, Kay S, Lee HM. Immunosuppresion as a high-risk factor in the development of condyloma accuminatum and squamous neoplasia of the cervix. Acta Cytol 1983;27: 220-4.
39. Alloub MI, Barr BB, Mclaren KM, Smith IW, Bunney MH, Smart GE. Human papillomavirus infection and cervical intraepithelial neoplasia in women with renal allografts. BMJ 1989;298:153-6.
40. ter Haar-van Eck SA, Rischen-Vos J, Chadha-Ajwani S, Huikeshoven FJ. The incidence of cervical intraepithelial neoplasia among women with renal transplant in relation to cyclosporine. Br J Obstet Gynecol 1995;102:58-61.
41. Blumenfeld Z, Lorber M, Yoffe N, Scharf Y. Sytemic lupus erythematosis: predisposition for uterine cervical dysplasia. Lupus 1994;3:59-61.
42. Frank MM, Austen KF, Claman HN, Unanue ER. Asthma. In: Samter's Immunologic Diseases. Fifth edition. Boston: Little, Brown and Company, 1995.
43. Pater MM, Mittai R, Pater A. Role of steroid hormones in potentiating transformation of cervical cells by human papillomaviruses. Trends Microbiol 1994; 235:229-35.